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Abstract Low density lipoprotein (LDL) oxidation within the arterial wall may contribute to the disease of atherosclerosis. We have investigated 
the conditions under which transferrin (the major iron-carrying protein in plasma) may release iron ions to catalyse the oxidation of LDL. Transferrin 
that had been incubated at pH 5.5 released approximately 10% of its bound iron in 24 h, as measured by ultrafiltration and atomic absorption 
spectroscopy. Furthermore, transfenin co-incubated with LDL and L-cysteine at pH 5.5 resulted in the oxidation of the LDL as measured by 
thiobarbituric acid-reactive substances and electrophoretic mobility. This effect was observed at transferrin concentrations as low as 40% of its average 
plasma concentration. The release of iron from transferrin in atherosclerotic lesions due to a localised acidic pH may help to explain why LDL 
oxidation occurs in these lesions. 
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1. Introduction 
The oxidation of low density lipoprotein (LDL) within the 
arterial wall may result in its increased uptake by macrophages 
converting them into cholesterol-laden foam cells, the migra- 
tion of monocytes into the arterial wall, cytotoxicity and many 
other effects that are involved in the disease of atherosclerosis 
VI. 
There is increasing evidence that iron may play an important 
role in promoting tissue damage at sites of inflammation [2]. 
Under normal physiological conditions, however, free iron 
does not exist in plasma or other extracellular fluids. It has been 
suggested, however, that free iron may become available fol- 
lowing release from transferrin [3,4] or ferritin [5] under certain 
conditions. 
Transferrin is the major iron transport protein of mammal- 
ian plasma. It is a polypeptide of M, 80,000 which, in the 
presence of bicarbonate, can bind two iron ions per molecule 
[6]. Transferrin in plasma is only around 33% saturated with 
iron [7]. 
It has been reported that an elevated serum ferritin level is 
a risk factor for acute myocardial infarction [8], but not all 
studies agree with this [9]. The total iron-binding capacity of 
serum (mainly due to transferrin) has been reported to be a 
negative risk factor for myocardial infarction [9], and transfer- 
rin saturation has been reported to be inversely associated with 
cardiovascular mortality [lo]. The epidemiology of iron status 
and atherosclerosis is, therefore, unclear. 
We have investigated the effect of acidic pH on transferrin 
to determine whether or not it can release bound iron ions 
which could catalyse the oxidation of LDL. 
*Corresponding author. Fax: (44) (734) 310 180. 
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; LDL, 
low density lipoprotein; MES, N-morpholinoethanesulphonic a id; 
TBARS, thiobarbituric acid-reactive substances. 
2. Materials and methods 
2.1. Isolation of LDL 
LDL (1.019-1.063 g/ml) was isolated from pooled normal human 
blood by sequential ultracentrifugation i  KBr solutions at 4°C as 
described elsewhere [1 11. 
2.2. Determination of iron release from transferrin 
All solutions were prepared fresh and treated with Chelex-100 prior 
to use. Transferrin 30% saturated with iron (Boehringer-Mannheim) 
was incubated in triplicate at 6 mg/ml in a 0.2 M MES buffer (pH 
7.45.5) containing 10 mM sodium bicarbonate for 24 h at 37°C. It was 
then filtered using a 30,000 M, cut-off microcentrifuge filter tube 
(Whatman) at 9500 x g for 25 min. The filtrate was then assayed for 
iron ions by atomic absorption spectroscopy. 
2.3. Co-incubation of transferrin and LDL 
LDL (100 pg protein/ml) was incubated in triplicate in the presence 
or absence of transferrin (2.4 mg/ml) in a 0.2 M MES buffer @H 
7.4-5.5) containing 10 mM sodium bicarbonate and 180 PM L-cysteine 
in 22 mm tissue culture wells (Coming) for 44 h at 37’X. 
2.4. Thiobarbituric acid-reactive substances (TBARS) assay 
Samples and appropriate standards (0.25 ml) were taken in triplicate 
and to each was added 3 ml 0.335% (w/v) thiobarbituric acid in 10% 
(w/v) trichloroacetic acid. They were then heated at 95°C for 15 min, 
centrifuged at 1500 x g for 5 min at 4”C, and the absorbance measured 
at 535 nm. 
2.5. Determination of LDL electrophoretic mobility 
Samples (5 ~1) were loaded onto a Beckman Paragon agarose gel and 
the gel electrophoresed at 100 V for 30 min, fixed, dryed and stained 
with the lipid stain Sudan black. The distance of LDL migration was 
then determined. 
3. Results 
Transferrin was incubated in the presence of bicarbonate at 
various pHs, subjected to ultrafiltration (M, cut-off 30,000) to 
separate protein from free iron and the released iron deter- 
mined by atomic absorption. The concentration of the 30% 
iron-saturated transferrin was 6 mg/ml and, therefore, con- 
tained around 45 PM iron. A higher concentration of transfer- 
rin was used for the atomic absorption work than was used for 
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Fig. 1. The effect of pH on the release of iron from transferrin. Trans- 
ferrin (6 ma/ml) was incubated for 24 h at 37°C in 0.2 M MES buffer 
of various pH values containing 10 mM NaHCO,. It was then filtered 
through a 30,000 A4, cut-off filter and the filtrate assayed for free iron 
by atomic absorption spectroscopy. The histobars represent the 
mean f S.E.M. of triplicates. These results were confirmed by an inde- 
pendent experiment. 
oxidising LDL because of the lower sensitivity of the atomic 
absorption technique. 
Transferrin incubated at pHs 7.4 and 7.0 released a negligible 
quantity of iron over 24 h (Fig. 1). At pHs 6.5 and 6.0 around 
0.75 PM iron ions were released. At pH 5.5, however, around 
4 PM iron ions were released from the transferrin, which repre- 
sents around 10% of the total iron bound to transferrin. 
When LDL was co-incubated with transferrin at pHs 7.4 and 
7.0 over 44 h, the LDL was not oxidised, as evidenced by the 
lack of TBARS generated (Fig. 2). Very low levels (~3 nmol 
MDA equivalentslmg LDL protein) of TBARS were generated 
by LDL co-incubated with transferrin at pHs 6.0 and 6.5, and 
even less by LDL incubated in the absence of transferrin at 
these pHs. When LDL was co-incubated with transferrin at pH 
5.5, however, the LDL was oxidised significantly. While the 
level of TBARS was modest, around 23 nmol MDA equiva- 
lents/mg LDL protein, the levels of TBARS generated by LDL 
incubated in the absence of transferrin at pH 5.5 was negligible. 
The levels of TBARS were mirrored by the electrophoretic 
mobilities of the LDLs in agarose gels (Table 1). LDL that had 
been co-incubated with transferrin at pH 5.5 migrated about 
twice as far as native LDL or LDL incubated in the absence 
of transferrin at pH 5.5. LDL incubated in the presence or 
absence of transferrin at pHs 6.0-7.4 did not migrate signifi- 
cantly further than native LDL. 
When LDL was co-incubated with transferrin at pH 5.5 at 
100% of the average plasma concentration of transferrin (taken 
as 2.4 mg/ml [7]), around 22 nmol MDA equivalents/mg LDL 
protein were generated over 44 h (Fig. 3). As the concentration 
of transferrin was decreased, the levels of TBARS decreased in 
a dose-dependent manner, so that at 40% of the plasma concen- 
tration (0.96 mg transferrin/ml) around 10 nmol MDA equiva- 
lentslmg LDL protein were generated. At 20% of the plasma 
concentration (0.48 mg transferrin/ml) or in the absence of 
transferrin only, low levels of TBARS (< 3 nmol MDA equiv- 
alents/mg LDL protein) were generated. 
4. Discussion 
The mechanism by which LDL is oxidised within the arterial 
wall is still unclear but it seems likely that it is catalysed by 
either copper or iron ions. There is some suggestion that iron 
status is associated with coronary heart disease, but this is 
highly controversial. The human normal aortic intima has been 
shown to contain 97 mg transferrin/lOO cc of tissue [12] (ap- 
proximately 8 pmol iron/l whole tissue) and 3 10 mg transferrinl 
kg dry tissue [13] (equivalent to 2.6 pmol iron/kg dry tissue). 
In addition, a human atherosclerotic plaque can contain 1.22 
g transferrin/kg dry tissue (equivalent o 10 pmol iron/kg dry 
tissue) [ 131. Gruel taken from human advanced atherosclerotic 
lesions has been shown to contain up to 56 PM catalytically 
active iron ions [14]. 
We have shown here that transferrin releases around 10% of 
its iron ions at acidic pH (Fig. l), and that these ions are capable 
of oxidising LDL to increase its electrophoretic mobility (Table 
1) and generate TBARS (Fig. 2). Welch [ 151 has shown that the 
pH required to remove the initial 10% of iron ions from trans- 
ferrin is 5.4, whilist a pH of 4.3 is required to remove the final 
10%: this supports the findings reported here. Transferrin incu- 
bated at pH 7.0 or over did not release its iron ions and could 
not catalyse the oxidation of LDL, suggesting that these ions 
are tightly bound within transferrin and are not able to redox- 
cycle in a way that can catalyse the oxidation of LDL. 
We have shown previously that acidic pH can increase the 
oxidation of LDL by iron ions as evidenced by conjugated 
diene formation and macrophage degradation [16]. In this sys- 
tem where LDL and transferrin are co-incubated at acidic pH, 
the increase in LDL oxidation observed at pH 5.5 will be due 
not only to the release of iron ions from transferrin but also to 
the low pH. There was no LDL oxidation at pH 7.0 and above. 
This was not simply due to iron not being very efficient at 
oxidising LDL at these pH values, because ultrafiltration and 
atomic absorption spectroscopy showed that the iron was still 
bound to the transferrin at these pH values. A MES buffer was 
used because it does not precipitate iron ions and allows them 
to catalyse LDL oxidation more efficiently than in a phosphate 
Table 1 
The effect of pH on the oxidation of LDL coincubated with transferrin 
as measured by electrophoretic mobility 
PH Distance migrated (mm) 
+ transferrin - transferrin 
5.5 20.5 10.0 
6.0 10.5 10.0 
6.5 10.0 10.0 
7.0 10.0 10.0 
1.4 10.0 10.0 
LDL (1OOpg protein/ml) was incubated for 44 h at 37°C in the presence 
or absence of transferrin (2.4 mg/ml) in 0.2 M MES buffer of various 
pHs containing 10 mM NaHCO, and 180 PM L-cysteine. The samples 
were then subjected to electrophoresis at 100 V for 30 min. The figures 
are the distances the LDL migrated in mm. Native LDL migrated 
9.5 mm. 
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buffer (data not shown). Kuzuya et al. f17] have demonstrated 
that phosphate buffers inhibit LDL oxidation by iron ions, 
possibly by binding to the iron. 
Transferrin is normally about 33% saturated with iron and 
has a mean plasma concentration of about 2.4 mg/ml [7]. The 
concentration of transfer~n used in these ex~r~ents to oxi- 
dise LDL was also 2.4 mg/ml and was 30% saturated with iron, 
and would therefore contain around 18 ,&I iron ions. Around 
10% of the total iron bound to transferrin was released at pH 
5.5 (see Fig. I). LDL oxidation was seen with concentrations 
of just 40% of the average plasma concentration of transfer&, 
when LDL oxidation was measured in terms of TBARS (Fig. 
3) or efectrophoretic mobility (data not shown). Since the nor- 
mal arterial wall can contain around 55% of the plasma concen- 
tration of transferrin [ 1 IL!], if the pH were to fall low enough then 
sufficient iron ions may be released to catalyse the oxidation 
of LDL. 
Transfer& at physiological concentrations or below can re- 
lease catal~i~lly active iron ions at acidic pH to catalyse the 
oxidation of LDL. But are atherosclerotic lesions acidic? The 
media of large arteries are one of the poorest perfused tissues 
in the human body and therefore have a low oxygen tension 
[18]. Atherosclerotic lesions in the intima re also poorly per- 
fused and this may similarly result in ischaemia, and this may 
lead to local lactic acidosis and therefore a low pH. Macro- 
phages in atherosclerotic lesions exhibit some of the charader- 
istics of activated macrophages (191, and the pH measured near 
an activated macrophage can be as low as 3.6 [ZO]. In addition, 
atherosclerosis i now widely recognised as being in many ways 
a type of chronic inflammatory disease, and, by analogy to 
other in~ammatory sites, the pH may be expected to fall below 
7.4 [Zl]. It is thus possible that atherosclerotic lesions may 
pH 5.5 pH 6.0 pH 6.5 pH 7.0 pH 7.4 
Fig. 2. The effect of pH on the oxidation of LDL co-incubated with 
transferrin as measured by TBARS. LDL (100 fig protein/ml) was 
incubated for 44 h at 37°C in the presence or absence of transfer~n 
(2.4 mglml) in 0.2 M MES buffer of various pH values containing IO 
mM NaHCG, and I80 PM t-cysteine. SampIes were then assayed for 
TBARS. The mean f S.E.M. of triplicate incubations are shown, These 
results were confirmed by four independent experiments. 
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Fig. 3. The oxidation of LDL co-incubated with various ~n~ntrations 
of transferrin at acidic pH. LDL (100,~g protein/ml) was incubated for 
44 h at 37°C in the presence of various ~n~ntrations of transferrin 
in 0.2 M MES buffer, pH 5.5, containing IOmM NaHCG, and 180pM 
L-cysteine, The mean transferrin con~ntration in plasma was taken as 
2.4 mgfml. Samples were then assayed for TBARS. The mean zt. S.E.M. 
of triplicate incubations are shown. These resufts were confirmed by 
four independent experiments. 
experience an extracellular pH below 7.4, especially within a 
cluster of macrophages, although there is, as yet, no direct 
evidence to support this. 
The oxidation of LDL in the arterial wall, resulting in an 
atherogenic form, is probably catalysed by transition metaf 
ions. It is possible that low local pN values within the arterial 
wall may release iron from transferrin (or copper from caeru- 
ioplasmin [22]) which may catalyse this oxidation of LDL. 
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